About this trial
The goal of this clinical trial is to learn the effects of robot-assisted therapy using the ArmeoSpring on upper limb function compared to conventional occupational therpay in individuals with cervical spinal cord injury (cSCI). The main questions it aims to answer are:
\- Which of the two forms of therapy, robot-assisted therapy or conventional occupational therapy, is more effective in terms of improving arm and hand function?
The study is designed as a cross-over trial, which means that each participant will receive both therapy forms consecutively, whereas the order is assigned randomly (either robot-assisted therapy first and then occupational therapy, or vice versa).
In addition to their clinical routine therapy , participants will:
* complete a baseline assessment * practice one therapy form (either robot-assisted or occupational therapy) with one arm for 6 weeks (3 x 30 min per week) * complete a intermediate assessment * practice the other therapy form (either occupational or robot-assisted therapy) with one arm for 6 weeks (3 x 30 min per week) * complete a post assessment * complete a follow-up assessment (if the post assessment was completed prior to 150 days post-injury)
Eligibility criteria
Qualifiers
Informed Consent signed by the subject
Intermediate (>16 days and ≤81 days post-injury) traumatic or non-traumatic cSCI during primary rehabilitation at the Swiss Paraplegic Centre (SPC)
Neurological level of injury: C1-T1
American Spinal Injury Association Impairment Scale (AIS): A-D
Disqualifiers
Inability to follow the procedures of the investigation
Severe concomitant neurological disease
Concomitant neurodegenerative or progressive diseases
Impairment of upper limb function due to peripheral nerve lesions
Trial design
Treatments tested in this trial
- Unilateral robot-assisted therapy (RT)
- Unilateral conventional occupational therapy (OT)